Precise, reliable, and repeatable results. With synthetic cell controls, these goals are achievable in your flow cytometry experiments. Reduce costs, save time and commercialize faster. Beads for spectral compensation, immunophenotyping, viability, and assay controls.
Location: United States, California, Emeryville
Employees: 51-200
Total raised: $34M
Founded date: 2012
Investors 1
| Date | Name | Website |
| - | Anterra Ca... | anterracap... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 06.02.2023 | - | $11M | Anterra Ca... |
| 22.07.2021 | Series A | $23M | - |
Mentions in press and media 7
| Date | Title | Description |
| 06.02.2023 | Slingshot Biosciences Raises $11M in Series A3 Financing | Slingshot Biosciences, an Emeryville, CA-based biotechnology company building an on-demand synthetic cell platform for customizing cell and cell line mimics, raised $11m in Series A3 financing. The round was co-led by Arch Venture Partners,... |
| 23.07.2021 | Got a top MBA and started a company? Here’s the potential opportunity cost of that decision | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Paid Content 4 metrics tell you all you need to know about your company's leadership From Indiggo... |
| 23.07.2021 | Got a top MBA and started a company? Here’s the potential opportunity cost of that decision | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Paid Content Why the Electricity 4.0 moment is here From Schneider Electric Earning a master’s de... |
| 22.07.2021 | Slingshot Biosciences : Announces $23 Million in Series A Financing | Slingshot Biosciences, a biotechnology company building the world’s first on-demand synthetic cell platform, today announced the closing of $23 million in a Series A financing. The investment was led by Northpond Ventures, with participatio... |
| 22.07.2021 | Slingshot Biosciences Raises $23M in Series A Financing | Slingshot Biosciences, a Emeryville, Calif.-based biotechnology company building an on-demand synthetic cell platform, closed a $23m Series A financing. The round was led by Northpond Ventures, with participation from ARCH Venture Partners ... |
| - | On-Demand Synthetic Cell Platform Company Slingshot Biosciences Secures $11 Million | Slingshot Biosciences announced it raised $11 million. These are the details. Slingshot Biosciences – a biotechnology company building the world’s first on-demand synthetic cell platform for customizing cell and cell line mimics – announced... |
| - | Slingshot Biosciences | “Slingshot Bio brings streamlined simplicity and accuracy to the complex world of cell analysis. Get reliable QC data fast, without the headaches.” |